Targeting multiplicity: the key factor for anti-cancer nanoparticles

Curr Med Chem. 2013;20(15):1946-55. doi: 10.2174/0929867311320150002.

Abstract

In this mini-review, we focus on different strategies to bring nanotools specifically to cancer cells. We discuss about a better targeting of tumor, combining the characteristics of tumor environment, the increase in nanoparticles life time, the biomarkers overexpressed on cancer cells and different physical methods for non invasive therapies. Here we detail the necessity of a synergy between passive and active targeting for an actual specificity of cancer cells.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / administration & dosage*
  • Drug Delivery Systems / methods*
  • Humans
  • Nanoparticles / analysis*
  • Neoplasms / blood supply
  • Neoplasms / drug therapy*
  • Neoplasms / metabolism
  • Oxygen / metabolism
  • Tumor Microenvironment

Substances

  • Antineoplastic Agents
  • Oxygen